|
|||||
|
|
Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway |
|
| Authors: | Yanyan Su Jiaqi Xu Siqi Chen Junxia Feng Jingchun Li Zihan Lei Lingyan Qiao Yaning Wang Dewang Zeng |
| Affiliation: | 1.Department of Nephrology, Affiliated Huadu Hospital, Southern Medical University (People’s Hospital of Huadu District), Guangzhou, China;2.The Central Laboratory, Affiliated Huadu Hospital, Southern Medical University (People’s Hospital of Huadu District), Guangzhou, China;3.Department of Diagnostics, The First Clinical Medical College of Binzhou Medical University, Yantai, China;4.Department of Nephrology, Binzhou Medical University Hospital, Binzhou, China |
| Abstract: | |
| Keywords: | Astragaloside IV acute kidney injury (AKI) chronic kidney injury keap1-Nrf2/ARE oxidative stress |